Targeting the JAK/STAT3 pathway with ruxolitinib for RDEB-cSCC therapy

被引：0
|
作者：
Jackow, J. [1 ]
Hayashi, R. [1 ]
Owens, D. [1 ]
Perez-Lorenzo, R. [1 ]
Hansen, C. [1 ]
DeLorenzo, D. [1 ]
Guo, Z. [1 ]
Christiano, A. [1 ]
机构：
[1] Columbia Univ, Dermatol, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 09期
关键词：
D O I：
10.1016/j.jid.2019.07.525
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
475
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [1] Modulation of antiangiogenic resistance: Targeting the JAK/STAT3 pathway in glioblastoma
    De Groot, John Frederick
    Liang, Ji
    Kong, Ling-Yuan
    Wei, Jun
    Piao, Yuji
    Fuller, Greg
    Qiao, Wei
    Heimberger, Amy B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Targeting the JAK2/STAT3 pathway in ovarian cancer
    Gritsina, Galina
    Xiao, Fang
    O'Brien, Shane W.
    Maglaty, Marisa A.
    Xu, Ren-Huan
    Sigal, Luis J.
    Litwin, Samuel
    Connolly, Denise C.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Targeting the STAT3 pathway with STAT3 degraders
    Wang, Zhijie
    Liao, Xiaotong
    He, Haiqi
    Guo, Xia
    Chen, Jianjun
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (09) : 811 - 823
  • [4] Targeting the JAK/STAT pathway for CTCL therapy
    Gu, Y.
    Perez-Duran, P.
    Oshima, K.
    Rodriguez-Cortes, J.
    Ferrando, A.
    Palomero, T.
    Geskin, L. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S115 - S115
  • [5] Targeting the JAK2/STAT3 signaling pathway for chronic pain
    Dai, Xin-Yi
    Liu, Lin
    Song, Fan-He
    Gao, Shao-Jie
    Wu, Jia-Yi
    Li, Dan-Yang
    Zhang, Long-Qing
    Liu, Dai-Qiang
    Zhou, Ya-Qun
    Mei, Wei
    AGING AND DISEASE, 2024, 15 (01): : 186 - 200
  • [6] The potential for targeting the STAT3 pathway as a novel therapy for melanoma
    Lesinski, Gregory B.
    FUTURE ONCOLOGY, 2013, 9 (07) : 925 - 927
  • [7] Targeting Stat3 in cancer therapy
    Jing, N
    Tweardy, DJ
    ANTI-CANCER DRUGS, 2005, 16 (06) : 601 - 607
  • [8] Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway
    Yang, Boshen
    Li, Taixi
    Wang, Zhixiang
    Zhu, Yuankang
    Niu, Kaifan
    Hu, Sien
    Lin, Zhiqi
    Zheng, Xinjie
    Jin, Xian
    Shen, Chengxing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (11): : 4314 - 4340
  • [9] Puerarin alleviates osteoporosis in rats by targeting the JAK2/STAT3 signaling pathway
    Zhao, Xinlei
    Zhou, Jiaxuan
    Liu, Yanqing
    Wang, Jianguo
    Liu, Youcai
    Wang, Beiyu
    Han, Caiting
    Zhao, Shengjie
    Zhang, Yijun
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (06): : 1651 - 1661
  • [10] Targeting the Jak/STAT pathway for immunosuppression
    O'Shea, JJ
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 67 - 71
12345